Graham Simmons - Publications

Affiliations: 
Vitalant Research Institute 

70 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Du L, Deiter F, Bouzidi MS, Billaud JN, Simmons G, Dabral P, Selvarajah S, Lingappa AF, Michon M, Yu SF, Paulvannan K, Manicassamy B, Lingappa VR, Boushey H, Greenland JR, et al. A viral assembly inhibitor blocks SARS-CoV-2 replication in airway epithelial cells. Communications Biology. 7: 486. PMID 38649430 DOI: 10.1038/s42003-024-06130-8  0.413
2024 Carroll TD, Wong T, Morris MK, Di Germanio C, Ma ZM, Stone M, Ball E, Fritts L, Rustagi A, Simmons G, Busch M, Miller CJ. Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2-Infected Hamsters. The Journal of Infectious Diseases. PMID 38213276 DOI: 10.1093/infdis/jiad568  0.327
2023 Chmielewski D, Wilson EA, Pintilie G, Zhao P, Chen M, Schmid MF, Simmons G, Wells L, Jin J, Singharoy A, Chiu W. Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans. Nature Communications. 14: 7175. PMID 37935678 DOI: 10.1038/s41467-023-42836-9  0.38
2023 Du L, Bouzidi MS, Gala A, Deiter F, Billaud JN, Yeung ST, Dabral P, Jin J, Simmons G, Dossani ZY, Niki T, Ndhlovu LC, Greenland JR, Pillai SK. Human galectin-9 potently enhances SARS-CoV-2 replication and inflammation in airway epithelial cells. Journal of Molecular Cell Biology. PMID 37127426 DOI: 10.1093/jmcb/mjad030  0.385
2023 Chmielewski D, Wilson E, Pintilie G, Zhao P, Chen M, Schmid M, Simmons G, Wells L, Jin J, Singharoy A, Chiu W. Integrated analyses reveal a hinge glycan regulates coronavirus spike tilting and virus infectivity. Research Square. PMID 36824920 DOI: 10.21203/rs.3.rs-2553619/v1  0.401
2023 Van Rompay KKA, Coffey LL, Yee JL, Singapuri A, Stuart J, Lanteri MC, Santa Maria F, Lu K, Singh I, Bakkour S, Stone M, Williamson PC, Muench MO, Busch MP, Simmons G. Plasma transfusion-transmission of Zika virus in mice and macaques. Transfusion. PMID 36621777 DOI: 10.1111/trf.17243  0.302
2022 Chmielewski D, Schmid MF, Simmons G, Jin J, Chiu W. Chikungunya virus assembly and budding visualized in situ using cryogenic electron tomography. Nature Microbiology. PMID 35773421 DOI: 10.1038/s41564-022-01164-2  0.346
2022 Lasswitz L, Zapatero-Belinchón FJ, Moeller R, Hülskötter K, Laurent T, Carlson LA, Goffinet C, Simmons G, Baumgärtner W, Gerold G. The Tetraspanin CD81 Is a Host Factor for Chikungunya Virus Replication. Mbio. e0073122. PMID 35612284 DOI: 10.1128/mbio.00731-22  0.374
2022 McCarthy EE, Odorizzi PM, Lutz E, Smullin CP, Tenvooren I, Stone M, Simmons G, Hunt PW, Feeney ME, Norris PJ, Busch MP, Spitzer MH, Rutishauser RL. A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection. Cell Reports. 39: 110815. PMID 35584677 DOI: 10.1016/j.celrep.2022.110815  0.32
2022 Du L, Bouzidi MS, Gala A, Deiter F, Billaud JN, Yeung ST, Dabral P, Jin J, Simmons G, Dossani Z, Niki T, Ndhlovu LC, Greenland JR, Pillai SK. Human Galectin-9 Potently Enhances SARS-CoV-2 Replication and Inflammation in Airway Epithelial Cells. Biorxiv : the Preprint Server For Biology. PMID 35378763 DOI: 10.1101/2022.03.18.484956  0.378
2021 Deere JD, Carroll TD, Dutra J, Fritts L, Sammak RL, Yee JL, Olstad KJ, Reader JR, Kistler A, Kamm J, Di Germanio C, Shaan Lakshmanappa Y, Elizaldi SR, Roh JW, Simmons G, et al. SARS-CoV-2 Infection of Rhesus Macaques Treated Early with Human COVID-19 Convalescent Plasma. Microbiology Spectrum. e0139721. PMID 34817208 DOI: 10.1128/Spectrum.01397-21  0.317
2021 Hsieh SC, Tsai WY, Tsai JJ, Stone M, Simmons G, Busch MP, Lanteri M, Stramer SL, Balmaseda A, Harris E, Wang WK. Identification of anti-premembrane antibody as a serocomplex-specific marker to discriminate Zika, dengue and West Nile virus infections. Journal of Virology. JVI0061921. PMID 34232731 DOI: 10.1128/JVI.00619-21  0.357
2021 Franz S, Pott F, Zillinger T, Schüler C, Dapa S, Fischer C, Passos V, Stenzel S, Chen F, Döhner K, Hartmann G, Sodeik B, Pessler F, Simmons G, Drexler JF, et al. Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction. Life Science Alliance. 4. PMID 34078739 DOI: 10.26508/lsa.202000909  0.543
2021 Calvert AE, Horiuchi K, Boroughs KL, Ong YT, Anderson KM, Biggerstaff BJ, Stone M, Simmons G, Busch MP, Huang CY. The Specificity of the Persistent IgM Neutralizing Antibody Response in Zika Viral Infections Among Individuals with Prior Dengue Virus Exposure. Journal of Clinical Microbiology. PMID 33980647 DOI: 10.1128/JCM.00400-21  0.34
2021 Shaan Lakshmanappa Y, Elizaldi SR, Roh JW, Schmidt BA, Carroll TD, Weaver KD, Smith JC, Verma A, Deere JD, Dutra J, Stone M, Franz S, Sammak RL, Olstad KJ, Rachel Reader J, ... ... Simmons G, et al. SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques. Nature Communications. 12: 541. PMID 33483492 DOI: 10.1038/s41467-020-20642-x  0.33
2020 Zhang K, Li S, Pintilie G, Chmielewski D, Schmid MF, Simmons G, Jin J, Chiu W. A 3.4-Å cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles. Qrb Discovery. 1: e11. PMID 34192263 DOI: 10.1017/qrd.2020.16  0.311
2020 Khanna K, Raymond W, Charbit AR, Jin J, Gitlin I, Tang M, Sperber HS, Franz S, Pillai S, Simmons G, Fahy JV. Binding of SARS-CoV-2 spike protein to ACE2 is disabled by thiol-based drugs; evidence from SARS-CoV-2 infection studies. Biorxiv : the Preprint Server For Biology. PMID 33330868 DOI: 10.1101/2020.12.08.415505  0.402
2020 Whitbeck JC, Thomas A, Kadash-Edmondson K, Grinyo-Escuer A, Stafford LJ, Cheng C, Liao GC, Holtsberg FW, Aman MJ, Simmons G, Davidson E, Doranz BJ. Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications. Plos Neglected Tropical Diseases. 14: e0008730. PMID 33206639 DOI: 10.1371/journal.pntd.0008730  0.322
2020 Elizaldi S, Lakshmanappa YS, Roh J, Schmidt B, Carroll T, Weaver K, Smith J, Deere J, Dutra J, Stone M, Franz S, Sammak R, Olstad K, Reader JR, Ma ZM, ... ... Simmons G, et al. SARS-CoV-2 infection induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques. Research Square. PMID 32818217 DOI: 10.21203/rs.3.rs-51545/v1  0.324
2020 Zhang K, Li S, Pintilie G, Chmielewski D, Schmid MF, Simmons G, Jin J, Chiu W. A 3.4-Å cryo-EM structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles. Biorxiv : the Preprint Server For Biology. PMID 32817943 DOI: 10.1101/2020.08.11.245696  0.313
2020 Elizaldi SR, Lakshmanappa YS, Roh JW, Schmidt BA, Carroll TD, Weaver KD, Smith JC, Deere JD, Dutra J, Stone M, Sammak RL, Olstad KJ, Reader JR, Ma ZM, Nguyen NK, ... ... Simmons G, et al. SARS-CoV-2 infection induces germinal center responses with robust stimulation of CD4 T follicular helper cells in rhesus macaques. Biorxiv : the Preprint Server For Biology. PMID 32676606 DOI: 10.1101/2020.07.07.191007  0.364
2020 Williamson PC, Biggerstaff BJ, Simmons G, Stone M, Winkelman V, Latoni G, Alsina J, Bakkour S, Newman C, Pate LL, Galel SA, Kleinman S, Busch MP. Evolving viral and serological stages of Zika virus RNA-positive blood donors and estimation of incidence of infection during the 2016 Puerto Rican Zika epidemic: an observational cohort study. The Lancet. Infectious Diseases. PMID 32673594 DOI: 10.1016/S1473-3099(19)30706-6  0.358
2020 Stone M, Bakkour S, Lanteri MC, Brambilla D, Simmons G, Bruhn R, Kaidarova Z, Lee TH, Orlando Alsina J, Williamson PC, Galel SA, Pate LL, Linnen JM, Kleinman S, Busch MP, et al. Zika virus RNA and IgM persistence in blood compartments and body fluids: a prospective observational study. The Lancet. Infectious Diseases. PMID 32673593 DOI: 10.1016/S1473-3099(19)30708-X  0.372
2020 Danh K, Karp DG, Robinson PV, Seftel D, Stone M, Simmons G, Bagri A, Schreibman M, Buser A, Holbro A, Battegay M, Corash LM, Hanson C, Tsai CT. Detection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assay. Medrxiv : the Preprint Server For Health Sciences. PMID 32577696 DOI: 10.1101/2020.05.28.20105692  0.302
2019 Webb EM, Azar SR, Haller SL, Langsjoen RM, Cuthbert CE, Ramjag AT, Luo H, Plante K, Wang T, Simmons G, Carrington CVF, Weaver SC, Rossi SL, Auguste AJ. Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential. Scientific Reports. 9: 20399. PMID 31892710 DOI: 10.1038/S41598-019-56551-3  0.354
2019 Braun E, Hotter D, Koepke L, Zech F, Groß R, Sparrer KMJ, Müller JA, Pfaller CK, Heusinger E, Wombacher R, Sutter K, Dittmer U, Winkler M, Simmons G, Jakobsen MR, et al. Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins. Cell Reports. 27: 2092-2104.e10. PMID 31091448 DOI: 10.1016/J.Celrep.2019.04.063  0.436
2019 Steffen I, Lu K, Yamamoto LK, Hoff NA, Mulembakani P, Wemakoy EO, Muyembe-Tamfum JJ, Ndembi N, Brennan CA, Hackett J, Stramer SL, Switzer WM, Saragosti S, Mbensa GO, Laperche S, ... ... Simmons G, et al. Serologic Prevalence of Ebola Virus in Equatorial Africa. Emerging Infectious Diseases. 25: 911-918. PMID 31002071 DOI: 10.3201/Eid2505.180115  0.319
2019 Henss L, Yue C, Kandler J, Faddy HM, Simmons G, Panning M, Lewis-Ximenez LL, Baylis SA, Schnierle BS. Establishment of an Alphavirus-Specific Neutralization Assay to Distinguish Infections with Different Members of the Semliki Forest complex. Viruses. 11. PMID 30669393 DOI: 10.3390/v11010082  0.425
2018 Hoff NA, Mukadi P, Doshi RH, Bramble MS, Lu K, Gadoth A, Sinai C, Spencer D, Nicholson BP, Williams R, Mossoko M, Ilunga-Kebela B, Wasiswa J, Okitolonda-Wemakoy E, Alfonso VH, ... ... Simmons G, et al. Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo. The Journal of Infectious Diseases. PMID 30239838 DOI: 10.1093/Infdis/Jiy499  0.381
2018 Jin J, Galaz-Montoya JG, Sherman MB, Sun SY, Goldsmith CS, O'Toole ET, Ackerman L, Carlson LA, Weaver SC, Chiu W, Simmons G. Neutralizing Antibodies Inhibit Chikungunya Virus Budding at the Plasma Membrane. Cell Host & Microbe. PMID 30146390 DOI: 10.1016/J.Chom.2018.07.018  0.505
2018 Bramble MS, Hoff N, Gilchuk P, Mukadi P, Lu K, Doshi RH, Steffen I, Nicholson BP, Lipson A, Vashist N, Sinai C, Spencer D, Olinger G, Wemakoy EO, Illunga BK, ... ... Simmons G, et al. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors. The Journal of Infectious Diseases. PMID 30107445 DOI: 10.1093/Infdis/Jiy453  0.343
2018 Jin J, Sherman MB, Chafets D, Dinglasan N, Lu K, Lee TH, Carlson LA, Muench MO, Simmons G. An attenuated replication-competent chikungunya virus with a fluorescently tagged envelope. Plos Neglected Tropical Diseases. 12: e0006693. PMID 30063703 DOI: 10.1371/journal.pntd.0006693  0.412
2017 Simmons G, Stone M, Busch MP. Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus Vaccination and Zika Virus Epidemics. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29301009 DOI: 10.1093/cid/cix972  0.312
2017 Rimoin AW, Lu K, Bramble MS, Steffen I, Doshi RH, Hoff NA, Mukadi P, Nicholson BP, Alfonso VH, Olinger G, Sinai C, Yamamoto LK, Ramirez CM, Okitolonda Wemakoy E, Kebela Illunga B, ... ... Simmons G, et al. Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection. The Journal of Infectious Diseases. PMID 29253164 DOI: 10.1093/Infdis/Jix584  0.344
2017 Tsai WY, Youn HH, Brites C, Tsai JJ, Tyson J, Pedroso C, Drexler JF, Stone M, Simmons G, Busch MP, Lanteri M, Stramer SL, Balmaseda A, Harris E, Wang WK. Distinguishing secondary dengue virus infection from Zika virus infection with previous dengue by a combination of three simple serological tests. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29020159 DOI: 10.1093/Cid/Cix672  0.43
2016 Jin J, Simmons G. Inhibitory antibodies targeting emerging viruses: advancements and mechanisms. Clinical and Vaccine Immunology : Cvi. PMID 27226280 DOI: 10.1128/CVI.00136-16  0.349
2016 Steffen I, Simmons G. Pseudotyping Viral Vectors With Emerging Virus Envelope Proteins. Current Gene Therapy. 16: 47-55. PMID 26785737  0.422
2015 Jin J, Liss NM, Chen DH, Liao M, Fox JM, Shimak RM, Fong RH, Chafets D, Bakkour S, Keating S, Fomin ME, Muench MO, Sherman MB, Doranz BJ, Diamond MS, ... Simmons G, et al. Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis. Cell Reports. PMID 26686638 DOI: 10.1016/J.Celrep.2015.11.043  0.367
2015 Wrensch F, Karsten CB, Gnirß K, Hoffmann M, Lu K, Takada A, Winkler M, Simmons G, Pöhlmann S. Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses. The Journal of Infectious Diseases. PMID 26034199 DOI: 10.1093/infdis/jiv255  0.376
2015 Zhou Y, Vedantham P, Lu K, Agudelo J, Carrion R, Nunneley JW, Barnard D, Pöhlmann S, McKerrow JH, Renslo AR, Simmons G. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Research. 116: 76-84. PMID 25666761 DOI: 10.1016/J.Antiviral.2015.01.011  0.485
2015 Bernard E, Hamel R, Neyret A, Ekchariyawat P, Molès JP, Simmons G, Chazal N, Desprès P, Missé D, Briant L. Human keratinocytes restrict chikungunya virus replication at a post-fusion step. Virology. 476: 1-10. PMID 25496825 DOI: 10.1016/J.Virol.2014.11.013  0.439
2013 Simmons G. Filovirus entry. Advances in Experimental Medicine and Biology. 790: 83-94. PMID 23884587 DOI: 10.1007/978-1-4614-7651-1_5  0.42
2013 Steffen I, Liss NM, Schneider BS, Fair JN, Chiu CY, Simmons G. Characterization of the Bas-Congo virus glycoprotein and its function in pseudotyped viruses. Journal of Virology. 87: 9558-68. PMID 23785218 DOI: 10.1128/JVI.01183-13  0.377
2013 Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, Krämer-Kühl A, Welsch K, Winkler M, Meyer B, Drosten C, Dittmer U, von Hahn T, Simmons G, Hofmann H, Pöhlmann S. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. Journal of Virology. 87: 5502-11. PMID 23468491 DOI: 10.1128/JVI.00128-13  0.484
2013 Salvador B, Sexton NR, Carrion R, Nunneley J, Patterson JL, Steffen I, Lu K, Muench MO, Lembo D, Simmons G. Filoviruses utilize glycosaminoglycans for their attachment to target cells. Journal of Virology. 87: 3295-304. PMID 23302881 DOI: 10.1128/JVI.01621-12  0.481
2012 Zhou Y, Steffen I, Montalvo L, Lee TH, Zemel R, Switzer WM, Tang S, Jia H, Heneine W, Winkelman V, Tailor CS, Ikeda Y, Simmons G. Development and application of a high-throughput microneutralization assay: lack of xenotropic murine leukemia virus-related virus and/or murine leukemia virus detection in blood donors. Transfusion. 52: 332-42. PMID 22239212 DOI: 10.1111/j.1537-2995.2011.03519.x  0.308
2011 Steffen I, Tyrrell DL, Stein E, Montalvo L, Lee TH, Zhou Y, Lu K, Switzer WM, Tang S, Jia H, Hockman D, Santer DM, Logan M, Landi A, Law J, ... ... Simmons G, et al. No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome. Plos One. 6: e27870. PMID 22114717 DOI: 10.1371/Journal.Pone.0027870  0.327
2011 Zhou Y, Agudelo J, Lu K, Goetz DH, Hansell E, Chen YT, Roush WR, McKerrow J, Craik CS, Amberg SM, Simmons G. Inhibitors of SARS-CoV entry--identification using an internally-controlled dual envelope pseudovirion assay. Antiviral Research. 92: 187-94. PMID 21820471 DOI: 10.1016/J.Antiviral.2011.07.016  0.406
2011 Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, Hackett J, Qiu X, Luk KC, Schochetman G, Knox A, Kogelnik AM, Levy JA. No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science (New York, N.Y.). 333: 94-7. PMID 21628393 DOI: 10.1126/Science.1204963  0.331
2011 Simmons G, Bertram S, Glowacka I, Steffen I, Chaipan C, Agudelo J, Lu K, Rennekamp AJ, Hofmann H, Bates P, Pöhlmann S. Different host cell proteases activate the SARS-coronavirus spike-protein for cell-cell and virus-cell fusion. Virology. 413: 265-74. PMID 21435673 DOI: 10.1016/J.Virol.2011.02.020  0.736
2011 Kumaki Y, Wandersee MK, Smith AJ, Zhou Y, Simmons G, Nelson NM, Bailey KW, Vest ZG, Li JK, Chan PK, Smee DF, Barnard DL. Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin. Antiviral Research. 90: 22-32. PMID 21338626 DOI: 10.1016/J.Antiviral.2011.02.003  0.462
2010 Switzer WM, Jia H, Hohn O, Zheng H, Tang S, Shankar A, Bannert N, Simmons G, Hendry RM, Falkenberg VR, Reeves WC, Heneine W. Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology. 7: 57. PMID 20594299 DOI: 10.1186/1742-4690-7-57  0.389
2010 Zhou Y, Lu K, Pfefferle S, Bertram S, Glowacka I, Drosten C, Pöhlmann S, Simmons G. A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms. Journal of Virology. 84: 8753-64. PMID 20573835 DOI: 10.1128/JVI.00554-10  0.385
2010 Glowacka I, Bertram S, Herzog P, Pfefferle S, Steffen I, Muench MO, Simmons G, Hofmann H, Kuri T, Weber F, Eichler J, Drosten C, Pöhlmann S. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. Journal of Virology. 84: 1198-205. PMID 19864379 DOI: 10.1128/JVI.01248-09  0.457
2009 Salvador B, Zhou Y, Michault A, Muench MO, Simmons G. Characterization of Chikungunya pseudotyped viruses: Identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein. Virology. 393: 33-41. PMID 19692105 DOI: 10.1016/j.virol.2009.07.013  0.499
2007 Kaletsky RL, Simmons G, Bates P. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. Journal of Virology. 81: 13378-84. PMID 17928356 DOI: 10.1128/Jvi.01170-07  0.713
2006 Simmons G, Rennekamp AJ, Bates P. Proteolysis of SARS-associated coronavirus spike glycoprotein. Advances in Experimental Medicine and Biology. 581: 235-40. PMID 17037535 DOI: 10.1007/978-0-387-33012-9_39  0.723
2006 Hofmann H, Simmons G, Rennekamp AJ, Chaipan C, Gramberg T, Heck E, Geier M, Wegele A, Marzi A, Bates P, Pöhlmann S. Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors. Journal of Virology. 80: 8639-52. PMID 16912312 DOI: 10.1128/Jvi.00560-06  0.658
2006 Marzi A, Akhavan A, Simmons G, Gramberg T, Hofmann H, Bates P, Lingappa VR, Pöhlmann S. The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. Journal of Virology. 80: 6305-17. PMID 16775318 DOI: 10.1128/Jvi.02545-05  0.597
2006 Qiu Z, Hingley ST, Simmons G, Yu C, Das Sarma J, Bates P, Weiss SR. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. Journal of Virology. 80: 5768-76. PMID 16731916 DOI: 10.1128/Jvi.00442-06  0.708
2006 Amberg SM, Netter RC, Simmons G, Bates P. Expanded Tropism and Altered Activation of a Retroviral Glycoprotein Resistant to an Entry Inhibitor Peptide Journal of Virology. 80: 353-359. PMID 16352560 DOI: 10.1128/Jvi.80.1.353-359.2006  0.63
2005 Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proceedings of the National Academy of Sciences of the United States of America. 102: 11876-81. PMID 16081529 DOI: 10.1073/Pnas.0505577102  0.684
2004 Marzi A, Gramberg T, Simmons G, Möller P, Rennekamp AJ, Krumbiegel M, Geier M, Eisemann J, Turza N, Saunier B, Steinkasserer A, Becker S, Bates P, Hofmann H, Pöhlmann S. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. Journal of Virology. 78: 12090-5. PMID 15479853 DOI: 10.1128/Jvi.78.21.12090-12095.2004  0.691
2004 Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proceedings of the National Academy of Sciences of the United States of America. 101: 4240-5. PMID 15010527 DOI: 10.1073/Pnas.0306446101  0.665
2004 Simmons G, Lee A, Rennekamp AJ, Fan X, Bates P, Shen H. Identification of murine T-cell epitopes in Ebola virus nucleoprotein. Virology. 318: 224-30. PMID 14972550 DOI: 10.1016/J.Virol.2003.09.016  0.595
2003 Simmons G, Rennekamp AJ, Chai N, Vandenberghe LH, Riley JL, Bates P. Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. Journal of Virology. 77: 13433-8. PMID 14645601 DOI: 10.1128/Jvi.77.24.13433-13438.2003  0.768
2003 Simmons G, Reeves JD, Grogan CC, Vandenberghe LH, Baribaud F, Whitbeck JC, Burke E, Buchmeier MJ, Soilleux EJ, Riley JL, Doms RW, Bates P, Pöhlmann S. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology. 305: 115-23. PMID 12504546 DOI: 10.1006/Viro.2002.1730  0.706
2003 Lin G, Simmons G, Pöhlmann S, Baribaud F, Ni H, Leslie GJ, Haggarty BS, Bates P, Weissman D, Hoxie JA, Doms RW. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. Journal of Virology. 77: 1337-46. PMID 12502850 DOI: 10.1128/Jvi.77.2.1337-1346.2003  0.669
2002 Simmons G, Wool-Lewis RJ, Baribaud F, Netter RC, Bates P. Ebola Virus Glycoproteins Induce Global Surface Protein Down-Modulation and Loss of Cell Adherence Journal of Virology. 76: 2518-2528. PMID 11836430 DOI: 10.1128/Jvi.76.5.2518-2528.2002  0.719
2001 Dejucq N, Simmons G, Clapham PR. T-cell line adaptation of human immunodeficiency virus type 1 strain SF162: effects on envelope, vpu and macrophage-tropism. The Journal of General Virology. 81: 2899-2904. PMID 11086121 DOI: 10.1099/0022-1317-81-12-2899  0.311
Show low-probability matches.